| P2093 | author name string | James O Lindsay | |
| | Andrew Silver | |
| | Roger Feakins | |
| | Amy Lewis | |
| | Anke Nijhuis | |
| | Shameer Mehta | |
| | Tomoko Kumagai | |
| P2860 | cites work | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| | MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA | Q24648090 |
| | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins | Q27863380 |
| | A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease | Q28304318 |
| | Treatment of HCV infection by targeting microRNA | Q29547712 |
| | Epithelial-mesenchymal transitions in development and pathologies | Q29614986 |
| | Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 |
| | Endothelial-to-mesenchymal transition contributes to cardiac fibrosis | Q29620566 |
| | Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease | Q33721980 |
| | How to train your dragon: targeted delivery of microRNA to cancer cells in vivo | Q33724285 |
| | Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. | Q33924416 |
| | The role of the miR-200 family in epithelial-mesenchymal transition | Q34123520 |
| | TGF-β-induced MiR-491-5p Expression Promotes Par-3 Degradation in Rat Proximal Tubular Epithelial Cells | Q34145044 |
| | Identification of microRNAs associated with ileal and colonic Crohn's disease | Q34159093 |
| | MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1 | Q34241853 |
| | Extracellular miRNAs: the mystery of their origin and function | Q44235487 |
| | MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis | Q44259722 |
| | The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. | Q45050841 |
| | Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice | Q46808312 |
| | NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis | Q47737388 |
| | Disease activity courses in a regional cohort of Crohn's disease patients. | Q50593816 |
| | ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma. | Q50929938 |
| | Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. | Q53547282 |
| | Circulating MicroRNA in inflammatory bowel disease | Q34258348 |
| | miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression | Q34448719 |
| | Short hairpin RNA-expressing bacteria elicit RNA interference in mammals | Q34525784 |
| | Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29 | Q34576966 |
| | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | Q34973748 |
| | Analysis of microRNA expression and function | Q35039269 |
| | Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum | Q35106915 |
| | TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29 | Q35142712 |
| | The myofibroblast in wound healing and fibrocontractive diseases | Q35170446 |
| | Extracellular microRNA: a new source of biomarkers | Q35417685 |
| | Human intestinal epithelial and smooth muscle cells are potent producers of IL-6. | Q35609255 |
| | Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases | Q35649473 |
| | The microcosmos of cancer | Q36432986 |
| | miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells | Q36733168 |
| | MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. | Q36768214 |
| | microRNAs and the immune response | Q37178538 |
| | Circulating microRNA is a biomarker of pediatric Crohn disease. | Q37254246 |
| | Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease | Q37318174 |
| | Intestinal fibrosis in IBD--a dynamic, multifactorial process | Q37433780 |
| | Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy | Q37438488 |
| | Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application | Q37665303 |
| | Physiological and pathological roles for microRNAs in the immune system | Q37680666 |
| | The road toward microRNA therapeutics | Q37708770 |
| | Predictors of fibrostenotic Crohn's disease | Q37838871 |
| | The role of EMT in renal fibrosis | Q37918449 |
| | Developing microRNA therapeutics | Q37981141 |
| | Oral delivery of small RNA and DNA. | Q38024612 |
| | A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. | Q39079687 |
| | Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles | Q39107059 |
| | MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms | Q39389208 |
| | Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly | Q39800747 |
| | Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis | Q39953406 |
| | Unemployment and disability in patients with moderately to severely active Crohn's disease | Q40432386 |
| | In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts | Q42223480 |
| | Cellular and molecular mechanisms of intestinal fibrosis | Q42252132 |
| | Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. | Q43407947 |
| | Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease | Q44070569 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| | microRNA | Q310899 |
| | biomarker | Q864574 |
| P304 | page(s) | 1141-1150 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets | |
| P478 | volume | 21 | |